Movement Disorders

Disease State Hub

Q&As

Movement Disorders

Takatoshi Kasai, MD, PhD, and Shoichiro Yatsu, MD, PhD, on RLS Prevalence in Patients With CAD

11/01/2019

Takatoshi Kasai, MD, PhD, and Shoichiro Yatsu, MD, PhD, are the lead authors on a new study that investigated the prevalence of restless legs syndrome in patients with coronary artery disease. Here are...

11/01/2019

Movement Disorders

Rachel Marie E. Salas, MD, on a New Era of Restless Legs Syndrome Management

11/16/2018

Rachel Marie E. Salas, MD, FAAN, at Johns Hopkins Medicine, answers our questions about restless legs syndrome.

11/16/2018

Research Summaries

FDA ALERT

FDA Approves First Treatment for Rare, Degenerative Disease

04/18/2023

Jessica Ganga

The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.

04/18/2023

Conference Coverage

An Overview of Parkinson Disease and Movement Disorders

11/18/2022

Jennifer Hui, MD, discusses the different movement disorders and elaborates on idiopathic Parkinson disease, discussing its symptoms and treatment, in her session at the Practical Updates in Primary Care...

11/18/2022

amyotrophic lateral sclerosis

FDA Approves New Medication for Treatment of ALS

10/07/2022

The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.

10/07/2022

Movement Disorders

FDA Approves New Add-on Therapy for Parkinson Disease

08/28/2019

After 4 clinical trials showed the treatment decreased daily “off” time, the FDA approved this new add-on therapy for adults with Parkinson disease.

08/28/2019

September 2023

Current Issue

September 2023

Volume 63

Issue 9